Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
-
VBL Therapeutics to Present at the Chardan 4th Annual Genetic Medicines Conference
-
Chardan Capital Markets Upgrades Vascular Biogenics Ltd (VBLT) to Buy
-
VBL Therapeutics to Present at Upcoming Conferences in October
-
Chardan Capital Markets Downgrades Vascular Biogenics Ltd (VBLT) to Neutral
-
Vascular Biogenics Ltd (VBLT) PT Raised to $25 at Chardan Capital Markets
-
VBL Therapeutics to Present at the Chardan Gene Therapy Conference
-
VBL Therapeutics (VBLT) Reports $20M at the Market Offering of Ordinary Shares
-
Vascular Biogenics Ltd. Announces Closing of $15 Million Underwritten Offering of Ordinary Shares and Warrants
-
Vascular Biogenics (VBLT) PT Raised to $27.50 at Chardan Capital Markets
-
Chardan Capital Affirms VBL Therapeutics (VBLT) at 'Buy' Following Strong VB-111 Combo Phase 2 Data
-
Unusual 11 Mid-Day Movers 9/22: (WPCS) (VBLT) (CANF) Higher; (WGBS) (OPHC) (TANH) Lower
-
Notable Analyst Rating Changes 9/22: (PYPL) (TSL) (ALL) Upgraded; (NTAP) (ABB) (ALSN) Downgraded
-
Pre-Open Stock Movers 09/22: (AMPE) (VBLT) (WFT) Higher; (FCX) (MRD) (HZNP) Lower (more...)
-
After Hours Stocks Movers 09/21: (VBLT) (TRXC) (CORE) Higher; (THO) (MRD) (NMFC) (more...)
-
Chardan Capital Markets Starts Vascular Biogenics Ltd (VBLT) at Buy, PT $25
-
Notable Analyst Rating Changes 5/22: (RWLK) (BAH) (DOV) Upgraded; (GD) (JGW) (CONN) Downgraded